N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine
![BK23TR | 1421372-66-8 | N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine](https://qncdn.chemcd.cn/alchemypharm/AP10539.png "BK23TR | 1421372-66-8 | N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine")
Catalog No.: BK23TR
CAS.RN：1421372-66-8
Molecular Formula: C25H31N7O
Molecular Weight: 445.56 g/mol
Purity: NLT 98%
Intermediates of Osimertinib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA8CN8 | Osimertinib API | 1421373-65-0 |
| BK94C0 | 3-(2-chloropyrimidin-4-yl)-1-methylindole | 1032452-86-0 |
| BK09U2 | N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine | 1421372-94-2 |
| BK21HH | 1-Methyl-1H-indole | 603-76-9 |
| BK8D25 | 2,4-Dichlorpyrimidin | 3934-20-1 |
| BK6LE0 | 4-Fluoro-2-methoxy-5-nitroaniline | 1075705-01-9 |
| BK205G | N-(2-dimethylamino-ethyl)-2-methoxy-N-methyl-N-[4-(1-methyl-1h-indol-3-yl)-pyrimidin-2-yl]-5-nitro-benzene-1,4-diamine | 1421372-67-9 |
| BK23TR | N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine | 1421372-66-8 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
